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Evaluation of a Simplified Measurement for Low Glomerular 
Filtration Rates With lndium-111 DTPA 
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A rapid new method for measuring glomerular filtration 
rates using "Vn diethylenetriamine pentaacetic acid CUn-
DTPA) was evaluated w i th 39 patients who showed 
marked impairment of renal function (creatinine clearance 
less than 20 ml/min). A simple, single compartment sys-
tem was assumed. For comparison, parallel inulin and 
creatinine clearances were performed. High linear cor-
relations (r = 0.96-0.97j were demonstrated when " V n -
DTPA clearances were compared with the standard non-
isotopic tests. Initial data indicate that reliable isotopic 
clearance values could be obtained for low clearances by 
withdrawing only two blood samples for assay at 6 and 48 
hours after isotope injection (without urine assay). 
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Due to difficulties with accepted techniques for measuring 
the glomerular filtration rate (CFR), efforts have concen-
trated on finding a simple yet accurate method for mea-
suring this renal function.'''^ The accepted standard is the 
inulin test, but assays are time consuming and the test is 
not routinely used in clinical practice. Clearance of endo-
genous creatinine is more widely used clinically, but it is 
not entirely satisfactory as a measure of very low glomeru-
lar filtration rates (CFR less than 20 ml/min). Existing 
methods for measuring filtration rates are liable to error in 
those cases which are associated with low urinary output, 
because of the difficulty of collecting accurate, complete 
urine specimens. Hence, a glomerular filtration measure-
ment method independent of urine specimens could be 
most useful. In addition to providing information needed 
for dialysis schedules, an easily performed measurement 
that did not require urine collection would benefit trans-
plant patients or those with urinary fistulae. 
Ideally, such a low GFR measurement should: 1) require 
only a few samples; 2) avoid urine collection; 3) be ad-
ministered in a simple, single test. 
Numerous attempts have been made to develop a ra-
dioactive test for measuring GFR. The substances studied 
have included =Tr-EDTA, ^^^Vb-DTPA, and ^^si.jothal-
mate.^"^ Using a continuous infusion method, Garnett, et 
al^ reported excellent correlation between ^^Cr-EDTA and 
inulin, while Milutinovic" achieved good results wfth ' '^^1-
iothalmate as compared to inulin in hemodialysis patients 
with low GFR. Thus far, however, none of the isotopic 
tagged material studied has been entirely accurate nor 
capable of establishing a completely linear relationship 
wfth inulin over the entire GFR range. Also, most of the 
existing studies have not concentrated on the very low 
CRF region. 
Formulating a test to measure GFR entails a comparison of 
clearance curves to determine optimum sampling inter-
vals, so that little or no information is lost when the 
number of assays is reduced. 
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Wfth these considerations in mind, a limited study was 
designed to collect data for comparing "Mn-DTPA clear-
ances wfth standard inulin and creatinine clearances. At 
the same time, the isotope technique was to be evaluated 
to determine the minimum number of collection points 
needed to obtain an accurate slope for the disappearance 
curve. 
This inftiai study used "Mn-DTPA to measure GFR. Di-
ethylenetriamine-pentaacetic acid (DTPA) is accepted as a 
suitable substance for measuring filtration rates.^'^'^ Its in 
vivo stability, which is lacking in such compounds as Fe-
DTPA and Tc Fe-ascorbate, is not significantly decreased 
by the In tag.^ Also, the " In tag has gamma emissions of 
173 keV and 247 keV suitable for studies of this type. The 
whole-body dose to the patient, primarily from the gamma 
emissions, is 48 mRad per 100 /xCi injection. For the 
patient with low CFR, the benefits outweigh the risks from 
the radiation dosage, providing useful clinical information 
in exchange for a modest diagnostic radiation exposure. 
Methods 
For all 39 patients in the study a catheter was inserted into 
the antecubital vein and a sample of urine was withdrawn 
for background counting. Two background blood samples 
were also withdrawn (6-8 cc each). Solutions containing 
150-200 ^t.Ci of "Mn-DTPA (a commercial sterile prepara-
tion of 500 p,C/m\ activity*) and 50 mg/kg of inulin were 
then injected intravenously and the time recorded. After 
injection, the venous catheter was attached either to a 
heparin lock or to a 5-10 cc syringe of heparin from which 
minute amounts were injected to maintain patency for 
subsequent blood withdrawals. 
After a 45-minute interval to allow for equilibration of the 
inulin and the tagged DTPA, blood and urine samples 
were collected for inulin, isotope clearance and endo-
genous creatinine measurements. Following equilibration, 
30-minute urine collections were made, from which 6 cc 
to 8 cc were obtained for the inulin analysis. For the 
isotope measurement, eight additional blood samples of 6 
cc were withdrawn beginning one hour postlnjection and 
continuing at 2, 4, 8, 12, 24 and 48 hours thereafter. The 
exact time of collection was noted for all samples, which 
were immediately refrigerated and cold-centrifuged for 15 
minutes at 2000 rpm (r=23 cm). Plasma and urine sam-
ples were frozen for later standard analysis when radioac-
tivity had reached negligible levels by decay. 
When all eight blood samples for radioassay had been 
collected over a two-day period, they were cold-cen-
trifuged for 15 minutes at 2000 rpm and plasma with-
drawn in 0.5 cc volumes. These samples and a standard 
volume were then radioassayed on a Searle multisample 
gamma counter with analyzer windows set to count both 
the 173 keV and 247 keV emissions of In. 
Standard procedures for measuring inulin and creatinine 
were used, and isotopic, creatinine, and inulin clearance 
values were obtained.^'^ 
In the usual two-compartment or mamillary^" model for 
renal clearance (Figure 1), the injected material disperses 
into the primary volume, the blood pool (compartment 1), 
which is exchanging with a closed volume (compartment 
2) at the same time as it is being lost from compartment 1 
into 3, from which no exchange back to 1 is permitted." 
Our "Mn-DTPA study used a single injection technique 
and a simplified mathematical description of the disap-
pearance process.'^'^^ Data collected by radioactive assay 
are converted to net counts/ml and treated graphically to 
determine " M n clearance from compartment 1. Net 
counts/ml are plotted versus actual wfthdrawal times 
postlnjection (Figure 2). The real disappearance curve is 
complex," as ft is the sum of more than one equilibrium 
and exchange process. The last portion of the plot, after 
about 60 to 120 minutes, is linear on a semi-log plot; ft 
represents the result of isotope disappearance from the 
blood pool after equilibrium has been established in the 
reservoirs. This linear portion may be extended back to 
Diagnostic Isotopes, Inc 
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Fig. 2 
A plot o f ' " I n -DTPA levels in the blood m (rateof change of concentration 
per unit t ime) is obtained from the slope established in the 4-48 hour 
period. Displacement of the two plots at 60 and 120 minutes represents 
the last phase of the early steep/ slope section of the total disappearance 
curve. 
the y-axis (by linear regression analysis) to find concentra-
tion A^. This concentration is accepted as the blood ac-
tivity per milliliter that would have existed at time zero, if 
dispersal had occurred instantly and been limited exclu-
sively to the vascular system. Use of this zero time value 
also assumes that other reservoirs (exchange wfth the 
blood pool) are negligible in size or do not carry out rapid 
interchange with the blood pool. 
Wfth this much simplified mathematical approach,^^ the 
clearance was calculated as follows: 
Clearance (ml/min) 
rn I 
Where m = slope of linear regression line (rate of 
change of In plasma concentration) 
A_ = 
total injected activity 
activity/ml at time zero (y-intercept value) 
These assumptions allow the test to be limited to a simple, 
single DTPA administration and a minimum of two plasma 
samples, as wi l l be shown. However, as long as compart-
ment 2 and free interchange exist, these assumptions wi l l 
result in a plotted disappearance slope that is too shallow 
and a plasma volume (A. derived from it that is on the 
degree to which these two error factors would compen-
sate for each other, particularly in low GFR subjects. 
Should they largely cancel out, then a simple, acceptable 
GFR test could result. 
Results and Discussion 
Thirty-nine patients wfth varied renal function were in-
jected w i th "Mn-DTPA, wh i ch was used to measure 
glomerular fiftration rates by measuring the changing iso-
topic "Mn blood levels. A few subjects wfth GFR greater 
than 20 ml/min were included for comparison. These 
higher clearances were done with "Mn and compared 
wfth simultaneous creatinine values. Simultaneous clear-
ances of efther inulin or creatinine were determined, wfth 
29 comparisons made to creatinine and 10 to inulin. 
The first 29 sets of data were plotted as "Mn-DTPA versus 
creatinine (Figure 3) and the second set of 10 data points 
was plotted as "Mn-DTPA versus inulin (Figure 4). The 
correlation coefficients for both (0.96 and 0.97, respec-
tively) are sufficiently high to infer a satisfactory linear 
relationship between the isotopic and the two nonisotopic 
standard methods. In this study, the slope of 1.24 in Figure 
3 indicates that "Mn-DTPA clearances, using the above 
assumptions, are lower than creatinine GFR values, while 
0 10 20 3 0 4 0 50 60 7 0 8 0 
IN-III-DTPA CLEARANCE (ml /m in ) 
Fig. 3 
h i g h s i d e . T h i s p i l o t s t u d y w a s d e s i g n e d t o a s c e r t a i n t h e " ' In-OTPA clearances compared to the creatinine values for 7 subiects. 
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TABLE I 
Comparison of GFR Values 
10 20 30 40 
I N - I I I - D T P A CLEARANCE ( m l / m i n ) 
Fig. 4 
Comparison of "Mn-DTPA and inulin clearances. Correlation coefficient 
is 0.97. DTPA values on average are greater than those for inulin. 
the slope of 0.84 in Figure 4 shows that "Mn-DTPA values 
are greater than inulin clearances 
Table I lists "Mn-DTPA clearances for 31 subjects calcu-
lated in two different ways. Column 2 contains clearance 
values obtained using all data points on the 4 to 48 hour 
linear portion of the clearance curve, whereas column 3 
indicates results using only two of the data points, at 
plasma collection times of 4 and about 48 hours. Column 
4, which lists the differences in clearance between the 6 
and 2 point data, indicates that the absolute differences 
are small and consistent for all subjects tested. Moreover, 
the coefficient of correlation between the data of column 
2 and column 3 is 0.997. The least squares line of the all-
point data plotted against the two-point plasma sampling 
has a slope of 1.01 and and intercept of - 0 . 0 1 . This 
provides strong evidence that the two-specimen method 
can accurately determine the slope m (GFR) of the disap-
pearance curve so that additional blood withdrawal is 
unnecessary. 
The tabular and graphic resufts indicate that GFR deter-
mined with "Mn-DTPA linearly follows both inulin and 
creatinine and has good correlation in the range of GFR 
less than 20 ml/min. In fact, "Mn-DTPA clearance values 
are lower than creatinine but higher than inulin. In the 
case of low GFR, "Mn-DTPA clearance is more accurate 
than creatinine and less accurate (on the high side) than 
Pat:ent 
All Point Plot 
Clearance 
2 Point Plot 
Clearance Dif ference 
1 6,1 6,2 0,2 
2 4.3 3,5 0,8 
3 8.2 8,6 0,4 
4 2.9 2,8 0,1 
5 3.0 2 8 0,2 
6 6.3 6,4 0,1 
7 5.8 6.0 0.2 
8 22.5 22.5 
— 
9 4.1 4.5 0.4 
^0 19.5 19.5 
— 
11 17.4 17.4 
— 
12 9.3 9.8 0,5 
13 9.4 11.0 1,6 
14 4.1 3.9 0.2 
15 8.0 7.9 0.1 
' 6 10.6 10.4 0.2 
17 16.9 17.3 0.4 
•8 12.6 12.2 0.4 
19 2.2 1.8 0,4 
20 4.3 4.3 
— 
21 2.7 3.0 0.3 
22 4,1 4.6 0.5 
23 9.4 10.1 0,7 
24 8.9 8.9 0,1 
25 11.4 11.1 0.3 
26 18.5 18.7 0.2 
27 6.6 6.8 0.2 
28 5.6 5.3 0.3 
29 12.7 13.1 0.4 
30 3.9 3.6 0.3 
31 3,7 3.7 
— 
inulin, when measured against inulin as the standard. It is 
not surprising that inulin GFRs are not duplicated pre-
cisely, since with the simplified theory the equation is an 
approximation, lacking a term in the denominator." The 
true picture is that of a two-pool mamillary system. With 
the second term in the denominator, it is likely that calcu-
lated clearances wi l l be higher than true inulin clearances. 
Thus, we may conclude that the "Mn-DTPA monitors 
clearance as consistently as creatinine does but gives a 
closer approximation to inulin values, inulin being the 
accepted standard of measurement. The two-plasma sam-
ple measurement with "Mn is certainly less liable to the 
serious systematic errors inevitably associated with urine 
collections and particularly from subjects with very low 
filtration rates. 
An interesting aspect of the "^ In-DTPA study has been the 
consistent production of the straight line disappearance 
plot for the 4-48 hour plasma collection. The slope is 
precisely and regularly delineated wfth an excellent r and 
may be accurately derived from only two plasma samples. 
Thus, this rate of change of blood "Mn-DTPA concentra-
tion (slope) may be the key to an acceptable, simplified 
clearance method for low GFR. This study also drew 
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blood samples to provide data that would determine the 
linear portion of the disappearance curve accurately (see 
Figure 1). While six data points were used to determine 
patient curves, we found that two data points could be 
used without any significant loss of accuracy (Table I). 
Conclusion 
Our study demonstrated the "Mn-DTPA may be used for 
an approximate determination of low GFR clearance, 
using a single-injection technique, withdrawal and count-
ing of only two blood samples, as well as a simplified 
expression for disappearance. This test could be sub-
stituted for routine creatinine clearances in low GFR pa-
tients in order to save time and reduce the discomfort of 
the patient. 
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